{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/25/3317235/0/en/HUTCHMED-Highlights-Pivotal-Phase-II-Data-for-Fanregratinib-in-Intrahepatic-Cholangiocarcinoma-Presented-at-ESMO-Gastrointestinal-Cancers-Congress-2026.html", "message": "News view counter 815795 successfully enlarged"}